VETMULIN 162 mg/ml Solution for Injection for pigs
VETMULIN 162 mg/ml Solution for Injection for pigs
Authorised
- Tiamulin
Product identification
Medicine name:
VETMULIN 162 mg/ml Solution for Injection for pigs
VETMULIN 162 MG/ML SOLUZIONE INIETTABILE
Active substance:
- Tiamulin
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Tiamulin162.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal21day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- The product is presented in a 100 ml Type I amber glass vial, sealed with a nitrile rubber stopper supplied in a carton.One vial per carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Ministry Of Health
Authorisation number:
- 104236
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0225/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Denmark
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 14/05/2022
Combined File of all Documents
English (PDF)
Download Published on: 14/09/2025
Italian (PDF)
Published on: 3/06/2022